nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—migraine—Prednisone—hematologic cancer	0.11	0.508	CpDpCtD
Indomethacin—osteoarthritis—Prednisone—hematologic cancer	0.106	0.492	CpDpCtD
Indomethacin—ABCC3—hematologic cancer	0.0943	0.439	CbGaD
Indomethacin—UGT1A1—hematologic cancer	0.0815	0.379	CbGaD
Indomethacin—ABCC6—Daunorubicin—hematologic cancer	0.0226	0.0652	CbGbCtD
Indomethacin—ALB—hematologic cancer	0.02	0.093	CbGaD
Indomethacin—ABCC6—Teniposide—hematologic cancer	0.0196	0.0567	CbGbCtD
Indomethacin—ABCB1—hematologic cancer	0.0191	0.0887	CbGaD
Indomethacin—ABCC4—Tioguanine—hematologic cancer	0.0155	0.0447	CbGbCtD
Indomethacin—ABCC11—Methotrexate—hematologic cancer	0.00997	0.0288	CbGbCtD
Indomethacin—ABCC6—Vinblastine—hematologic cancer	0.00962	0.0278	CbGbCtD
Indomethacin—ABCC1—Idarubicin—hematologic cancer	0.00943	0.0272	CbGbCtD
Indomethacin—ABCC6—Cisplatin—hematologic cancer	0.00882	0.0254	CbGbCtD
Indomethacin—ABCC6—Etoposide—hematologic cancer	0.00867	0.025	CbGbCtD
Indomethacin—SLCO1A2—Chlorambucil—hematologic cancer	0.00842	0.0243	CbGbCtD
Indomethacin—PTGS2—Lenalidomide—hematologic cancer	0.00832	0.024	CbGbCtD
Indomethacin—AKR1C3—Doxorubicin—hematologic cancer	0.00786	0.0227	CbGbCtD
Indomethacin—CES1—Irinotecan—hematologic cancer	0.00782	0.0226	CbGbCtD
Indomethacin—ABCC1—Daunorubicin—hematologic cancer	0.00667	0.0192	CbGbCtD
Indomethacin—ABCC4—Mercaptopurine—hematologic cancer	0.00643	0.0185	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—hematologic cancer	0.00591	0.0171	CbGbCtD
Indomethacin—UGT1A1—Nilotinib—hematologic cancer	0.00565	0.0163	CbGbCtD
Indomethacin—ABCC2—Daunorubicin—hematologic cancer	0.00494	0.0142	CbGbCtD
Indomethacin—UGT1A9—Irinotecan—hematologic cancer	0.00475	0.0137	CbGbCtD
Indomethacin—UGT2B7—Epirubicin—hematologic cancer	0.00462	0.0133	CbGbCtD
Indomethacin—ABCC3—Vincristine—hematologic cancer	0.00454	0.0131	CbGbCtD
Indomethacin—PTGS2—Thalidomide—hematologic cancer	0.00444	0.0128	CbGbCtD
Indomethacin—PTGS1—Bortezomib—hematologic cancer	0.00431	0.0124	CbGbCtD
Indomethacin—ABCC3—Cisplatin—hematologic cancer	0.00424	0.0122	CbGbCtD
Indomethacin—ABCC3—Etoposide—hematologic cancer	0.00416	0.012	CbGbCtD
Indomethacin—ABCC1—Mitoxantrone—hematologic cancer	0.00405	0.0117	CbGbCtD
Indomethacin—SLC22A8—Mercaptopurine—hematologic cancer	0.00402	0.0116	CbGbCtD
Indomethacin—UGT1A1—Irinotecan—hematologic cancer	0.00388	0.0112	CbGbCtD
Indomethacin—PTGS1—Thalidomide—hematologic cancer	0.00375	0.0108	CbGbCtD
Indomethacin—PTGS1—Ifosfamide—hematologic cancer	0.0033	0.00953	CbGbCtD
Indomethacin—ABCC1—Epirubicin—hematologic cancer	0.00328	0.00947	CbGbCtD
Indomethacin—ABCC1—Irinotecan—hematologic cancer	0.00319	0.00921	CbGbCtD
Indomethacin—SLCO1A2—Prednisolone—hematologic cancer	0.00318	0.00918	CbGbCtD
Indomethacin—PTGS1—Imatinib—hematologic cancer	0.00316	0.00911	CbGbCtD
Indomethacin—UGT1A1—Etoposide—hematologic cancer	0.00311	0.00897	CbGbCtD
Indomethacin—PTGS2—Triamcinolone—hematologic cancer	0.00308	0.00889	CbGbCtD
Indomethacin—SLCO1A2—Prednisone—hematologic cancer	0.00301	0.00867	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—hematologic cancer	0.00284	0.00819	CbGbCtD
Indomethacin—ABCC1—Vinblastine—hematologic cancer	0.00284	0.00819	CbGbCtD
Indomethacin—CYP2C9—Bexarotene—hematologic cancer	0.00283	0.00816	CbGbCtD
Indomethacin—ABCC1—Vincristine—hematologic cancer	0.00279	0.00805	CbGbCtD
Indomethacin—ABCC3—Methotrexate—hematologic cancer	0.00275	0.00794	CbGbCtD
Indomethacin—ABCB1—Lenalidomide—hematologic cancer	0.00275	0.00792	CbGbCtD
Indomethacin—SLCO1B1—Irinotecan—hematologic cancer	0.00269	0.00776	CbGbCtD
Indomethacin—PTGS2—Betamethasone—hematologic cancer	0.00264	0.00762	CbGbCtD
Indomethacin—ABCC1—Etoposide—hematologic cancer	0.00256	0.00738	CbGbCtD
Indomethacin—ABCC2—Irinotecan—hematologic cancer	0.00236	0.00682	CbGbCtD
Indomethacin—ALB—Imatinib—hematologic cancer	0.00236	0.0068	CbGbCtD
Indomethacin—CYP2C9—Idarubicin—hematologic cancer	0.00234	0.00676	CbGbCtD
Indomethacin—SLC22A11—Methotrexate—hematologic cancer	0.00226	0.00651	CbGbCtD
Indomethacin—SLC22A7—Methotrexate—hematologic cancer	0.00215	0.00621	CbGbCtD
Indomethacin—ABCC4—Methotrexate—hematologic cancer	0.0021	0.00606	CbGbCtD
Indomethacin—ABCC2—Vinblastine—hematologic cancer	0.0021	0.00606	CbGbCtD
Indomethacin—CYP2C19—Bortezomib—hematologic cancer	0.00209	0.00602	CbGbCtD
Indomethacin—ABCC2—Vincristine—hematologic cancer	0.00206	0.00596	CbGbCtD
Indomethacin—ABCC2—Cisplatin—hematologic cancer	0.00193	0.00556	CbGbCtD
Indomethacin—PTGS2—Cisplatin—hematologic cancer	0.0019	0.00549	CbGbCtD
Indomethacin—ABCC2—Etoposide—hematologic cancer	0.00189	0.00546	CbGbCtD
Indomethacin—SLCO1A2—Dexamethasone—hematologic cancer	0.00188	0.00541	CbGbCtD
Indomethacin—PTGS2—Etoposide—hematologic cancer	0.00187	0.00539	CbGbCtD
Indomethacin—PTGDR2—hematopoietic system—hematologic cancer	0.00182	0.052	CbGeAlD
Indomethacin—CYP2C19—Thalidomide—hematologic cancer	0.00182	0.00524	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—hematologic cancer	0.00174	0.00503	CbGbCtD
Indomethacin—CYP2C9—Bortezomib—hematologic cancer	0.00173	0.005	CbGbCtD
Indomethacin—CYP2C19—Teniposide—hematologic cancer	0.00173	0.005	CbGbCtD
Indomethacin—ABCC1—Methotrexate—hematologic cancer	0.00169	0.00487	CbGbCtD
Indomethacin—ABCB1—Daunorubicin—hematologic cancer	0.00161	0.00464	CbGbCtD
Indomethacin—CYP2C19—Ifosfamide—hematologic cancer	0.0016	0.00462	CbGbCtD
Indomethacin—PTGS1—Etoposide—hematologic cancer	0.00158	0.00456	CbGbCtD
Indomethacin—ABCB1—Alitretinoin—hematologic cancer	0.00158	0.00455	CbGbCtD
Indomethacin—ABCC2—Dexamethasone—hematologic cancer	0.00156	0.00449	CbGbCtD
Indomethacin—ALB—Prednisone—hematologic cancer	0.00155	0.00448	CbGbCtD
Indomethacin—PTGS2—Dexamethasone—hematologic cancer	0.00154	0.00444	CbGbCtD
Indomethacin—CYP2C19—Imatinib—hematologic cancer	0.00153	0.00441	CbGbCtD
Indomethacin—CYP2C9—Thalidomide—hematologic cancer	0.00151	0.00436	CbGbCtD
Indomethacin—PTGS2—ovarian follicle—hematologic cancer	0.00151	0.0431	CbGeAlD
Indomethacin—SLCO1A2—Methotrexate—hematologic cancer	0.00151	0.00435	CbGbCtD
Indomethacin—ALB—Irinotecan—hematologic cancer	0.00147	0.00425	CbGbCtD
Indomethacin—CYP2C9—Teniposide—hematologic cancer	0.00144	0.00416	CbGbCtD
Indomethacin—SLCO1B1—Methotrexate—hematologic cancer	0.00142	0.0041	CbGbCtD
Indomethacin—CYP2C9—Ifosfamide—hematologic cancer	0.00133	0.00384	CbGbCtD
Indomethacin—SLC22A8—Methotrexate—hematologic cancer	0.00131	0.00379	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—hematologic cancer	0.00129	0.00372	CbGbCtD
Indomethacin—CYP2C9—Imatinib—hematologic cancer	0.00127	0.00367	CbGbCtD
Indomethacin—ABCC2—Methotrexate—hematologic cancer	0.00125	0.00361	CbGbCtD
Indomethacin—ABCB1—Imatinib—hematologic cancer	0.00123	0.00356	CbGbCtD
Indomethacin—PTGDR2—blood—hematologic cancer	0.00121	0.0345	CbGeAlD
Indomethacin—CYP2C9—Nilotinib—hematologic cancer	0.00115	0.00333	CbGbCtD
Indomethacin—ABCB1—Nilotinib—hematologic cancer	0.00112	0.00323	CbGbCtD
Indomethacin—ABCB1—Vinorelbine—hematologic cancer	0.00111	0.00321	CbGbCtD
Indomethacin—CYP2C19—Prednisone—hematologic cancer	0.00101	0.0029	CbGbCtD
Indomethacin—ABCB1—Dasatinib—hematologic cancer	0.00099	0.00286	CbGbCtD
Indomethacin—ABCB1—Mitoxantrone—hematologic cancer	0.000978	0.00282	CbGbCtD
Indomethacin—SLC22A6—Methotrexate—hematologic cancer	0.000915	0.00264	CbGbCtD
Indomethacin—ABCC11—gonad—hematologic cancer	0.00091	0.026	CbGeAlD
Indomethacin—ABCB1—Betamethasone—hematologic cancer	0.000872	0.00252	CbGbCtD
Indomethacin—ABCB1—Gemcitabine—hematologic cancer	0.000864	0.00249	CbGbCtD
Indomethacin—ABCB1—Prednisolone—hematologic cancer	0.00086	0.00248	CbGbCtD
Indomethacin—ABCB1—Prednisone—hematologic cancer	0.000812	0.00234	CbGbCtD
Indomethacin—PTGR2—blood—hematologic cancer	0.000801	0.0229	CbGeAlD
Indomethacin—ALB—Methotrexate—hematologic cancer	0.000779	0.00225	CbGbCtD
Indomethacin—ABCB1—Irinotecan—hematologic cancer	0.00077	0.00222	CbGbCtD
Indomethacin—GLO1—hematopoietic system—hematologic cancer	0.000747	0.0213	CbGeAlD
Indomethacin—PTGR2—lung—hematologic cancer	0.000702	0.0201	CbGeAlD
Indomethacin—PLA2G2A—hematopoietic system—hematologic cancer	0.000694	0.0198	CbGeAlD
Indomethacin—ABCC6—hematopoietic system—hematologic cancer	0.000687	0.0196	CbGeAlD
Indomethacin—ABCB1—Vinblastine—hematologic cancer	0.000685	0.00198	CbGbCtD
Indomethacin—ABCB1—Vincristine—hematologic cancer	0.000673	0.00194	CbGbCtD
Indomethacin—PTGR2—testis—hematologic cancer	0.000663	0.0189	CbGeAlD
Indomethacin—ABCC11—testis—hematologic cancer	0.000656	0.0187	CbGeAlD
Indomethacin—PPARA—hematopoietic system—hematologic cancer	0.000649	0.0185	CbGeAlD
Indomethacin—CYP2C9—Cisplatin—hematologic cancer	0.000647	0.00187	CbGbCtD
Indomethacin—CYP2C19—Dexamethasone—hematologic cancer	0.000629	0.00181	CbGbCtD
Indomethacin—ABCB1—Cisplatin—hematologic cancer	0.000628	0.00181	CbGbCtD
Indomethacin—ABCB1—Etoposide—hematologic cancer	0.000617	0.00178	CbGbCtD
Indomethacin—GLO1—gonad—hematologic cancer	0.000568	0.0162	CbGeAlD
Indomethacin—CYP2C9—Dexamethasone—hematologic cancer	0.000523	0.00151	CbGbCtD
Indomethacin—ABCB1—Dexamethasone—hematologic cancer	0.000507	0.00146	CbGbCtD
Indomethacin—UGT1A1—hematopoietic system—hematologic cancer	0.000497	0.0142	CbGeAlD
Indomethacin—GLO1—blood—hematologic cancer	0.000495	0.0141	CbGeAlD
Indomethacin—CES1—hematopoietic system—hematologic cancer	0.000481	0.0137	CbGeAlD
Indomethacin—PTGR2—lymph node—hematologic cancer	0.00048	0.0137	CbGeAlD
Indomethacin—GLO1—bone marrow—hematologic cancer	0.000479	0.0137	CbGeAlD
Indomethacin—SLC10A1—gonad—hematologic cancer	0.000474	0.0135	CbGeAlD
Indomethacin—PLA2G2A—blood—hematologic cancer	0.00046	0.0131	CbGeAlD
Indomethacin—CXCL8—blood—hematologic cancer	0.000455	0.013	CbGeAlD
Indomethacin—ABCC6—blood—hematologic cancer	0.000455	0.013	CbGeAlD
Indomethacin—CXCL8—bone marrow—hematologic cancer	0.000441	0.0126	CbGeAlD
Indomethacin—GLO1—lung—hematologic cancer	0.000434	0.0124	CbGeAlD
Indomethacin—PPARA—blood—hematologic cancer	0.00043	0.0123	CbGeAlD
Indomethacin—ABCB1—Doxorubicin—hematologic cancer	0.000421	0.00121	CbGbCtD
Indomethacin—SLCO1B1—hematopoietic system—hematologic cancer	0.000414	0.0118	CbGeAlD
Indomethacin—GLO1—testis—hematologic cancer	0.000409	0.0117	CbGeAlD
Indomethacin—ABCB1—Methotrexate—hematologic cancer	0.000408	0.00118	CbGbCtD
Indomethacin—PLA2G2A—lung—hematologic cancer	0.000403	0.0115	CbGeAlD
Indomethacin—CXCL8—lung—hematologic cancer	0.000399	0.0114	CbGeAlD
Indomethacin—ABCC6—lung—hematologic cancer	0.000399	0.0114	CbGeAlD
Indomethacin—ABCC3—hematopoietic system—hematologic cancer	0.000392	0.0112	CbGeAlD
Indomethacin—PLA2G2A—testis—hematologic cancer	0.000381	0.0109	CbGeAlD
Indomethacin—PPARA—lung—hematologic cancer	0.000377	0.0108	CbGeAlD
Indomethacin—CXCL8—testis—hematologic cancer	0.000377	0.0108	CbGeAlD
Indomethacin—AKR1C3—blood—hematologic cancer	0.000357	0.0102	CbGeAlD
Indomethacin—PPARG—hematopoietic system—hematologic cancer	0.000357	0.0102	CbGeAlD
Indomethacin—PPARA—testis—hematologic cancer	0.000355	0.0102	CbGeAlD
Indomethacin—AKR1C3—bone marrow—hematologic cancer	0.000346	0.00987	CbGeAlD
Indomethacin—SLC10A1—testis—hematologic cancer	0.000342	0.00976	CbGeAlD
Indomethacin—SLCO1A2—hematopoietic system—hematologic cancer	0.000337	0.00961	CbGeAlD
Indomethacin—UGT1A1—blood—hematologic cancer	0.000329	0.0094	CbGeAlD
Indomethacin—ABCC4—hematopoietic system—hematologic cancer	0.000324	0.00925	CbGeAlD
Indomethacin—SLC22A8—hematopoietic system—hematologic cancer	0.000321	0.00918	CbGeAlD
Indomethacin—UGT2B7—testis—hematologic cancer	0.00032	0.00915	CbGeAlD
Indomethacin—CES1—blood—hematologic cancer	0.000319	0.00911	CbGeAlD
Indomethacin—AKR1C3—lung—hematologic cancer	0.000313	0.00894	CbGeAlD
Indomethacin—SLC22A7—testis—hematologic cancer	0.000305	0.0087	CbGeAlD
Indomethacin—GLO1—lymph node—hematologic cancer	0.000297	0.00847	CbGeAlD
Indomethacin—AKR1C3—testis—hematologic cancer	0.000295	0.00843	CbGeAlD
Indomethacin—CES1—lung—hematologic cancer	0.00028	0.00798	CbGeAlD
Indomethacin—PLA2G2A—lymph node—hematologic cancer	0.000276	0.00788	CbGeAlD
Indomethacin—SLCO1B1—blood—hematologic cancer	0.000274	0.00782	CbGeAlD
Indomethacin—CXCL8—lymph node—hematologic cancer	0.000273	0.0078	CbGeAlD
Indomethacin—CYP2C19—hematopoietic system—hematologic cancer	0.000269	0.00769	CbGeAlD
Indomethacin—CES1—testis—hematologic cancer	0.000264	0.00753	CbGeAlD
Indomethacin—Naproxen—UGT1A1—hematologic cancer	0.000261	0.45	CrCbGaD
Indomethacin—ABCC3—blood—hematologic cancer	0.00026	0.00742	CbGeAlD
Indomethacin—PPARA—lymph node—hematologic cancer	0.000258	0.00736	CbGeAlD
Indomethacin—Tolmetin—MPO—hematologic cancer	0.000255	0.439	CrCbGaD
Indomethacin—PPARG—blood—hematologic cancer	0.000236	0.00675	CbGeAlD
Indomethacin—ABCC6—Podofilox—Teniposide—hematologic cancer	0.000229	0.124	CbGdCrCtD
Indomethacin—PPARG—bone marrow—hematologic cancer	0.000229	0.00653	CbGeAlD
Indomethacin—ABCC3—lung—hematologic cancer	0.000228	0.00651	CbGeAlD
Indomethacin—ABCC3—testis—hematologic cancer	0.000215	0.00614	CbGeAlD
Indomethacin—ABCC4—blood—hematologic cancer	0.000215	0.00613	CbGeAlD
Indomethacin—AKR1C3—lymph node—hematologic cancer	0.000214	0.00611	CbGeAlD
Indomethacin—SLC22A8—blood—hematologic cancer	0.000213	0.00608	CbGeAlD
Indomethacin—CYP2C9—hematopoietic system—hematologic cancer	0.000209	0.00597	CbGeAlD
Indomethacin—ABCC2—blood—hematologic cancer	0.000208	0.00593	CbGeAlD
Indomethacin—ABCC4—bone marrow—hematologic cancer	0.000208	0.00593	CbGeAlD
Indomethacin—PPARG—lung—hematologic cancer	0.000207	0.00592	CbGeAlD
Indomethacin—AKR1C3—Podofilox—Teniposide—hematologic cancer	0.0002	0.108	CbGdCrCtD
Indomethacin—PPARG—testis—hematologic cancer	0.000195	0.00558	CbGeAlD
Indomethacin—SLCO1A2—lung—hematologic cancer	0.000195	0.00558	CbGeAlD
Indomethacin—CES1—lymph node—hematologic cancer	0.000191	0.00546	CbGeAlD
Indomethacin—PTGS1—hematopoietic system—hematologic cancer	0.000191	0.00545	CbGeAlD
Indomethacin—ABCC4—lung—hematologic cancer	0.000188	0.00537	CbGeAlD
Indomethacin—SLCO1A2—testis—hematologic cancer	0.000184	0.00527	CbGeAlD
Indomethacin—ALB—testis—hematologic cancer	0.000183	0.00524	CbGeAlD
Indomethacin—ABCC1—blood—hematologic cancer	0.000183	0.00523	CbGeAlD
Indomethacin—PTGS2—hematopoietic system—hematologic cancer	0.000182	0.00521	CbGeAlD
Indomethacin—PPARG—Ponatinib—Nilotinib—hematologic cancer	0.000181	0.0977	CbGdCrCtD
Indomethacin—CYP2C19—blood—hematologic cancer	0.000178	0.0051	CbGeAlD
Indomethacin—ABCC4—testis—hematologic cancer	0.000178	0.00507	CbGeAlD
Indomethacin—ABCC2—testis—hematologic cancer	0.000172	0.00491	CbGeAlD
Indomethacin—ABCC1—lung—hematologic cancer	0.00016	0.00458	CbGeAlD
Indomethacin—ABCC3—lymph node—hematologic cancer	0.000156	0.00445	CbGeAlD
Indomethacin—ABCC1—testis—hematologic cancer	0.000151	0.00432	CbGeAlD
Indomethacin—PPARG—lymph node—hematologic cancer	0.000142	0.00405	CbGeAlD
Indomethacin—CYP2C9—blood—hematologic cancer	0.000138	0.00395	CbGeAlD
Indomethacin—PPARG—Ponatinib—Imatinib—hematologic cancer	0.000137	0.074	CbGdCrCtD
Indomethacin—ABCC6—Podofilox—Etoposide—hematologic cancer	0.000136	0.0735	CbGdCrCtD
Indomethacin—ALB—lymph node—hematologic cancer	0.000133	0.0038	CbGeAlD
Indomethacin—PPARG—Topotecan—Irinotecan—hematologic cancer	0.00013	0.0702	CbGdCrCtD
Indomethacin—PPARG—Etoposide—Teniposide—hematologic cancer	0.000129	0.0697	CbGdCrCtD
Indomethacin—ABCC4—lymph node—hematologic cancer	0.000129	0.00367	CbGeAlD
Indomethacin—AKR1C3—Vincristine—Vinorelbine—hematologic cancer	0.000127	0.0688	CbGdCrCtD
Indomethacin—PTGS1—blood—hematologic cancer	0.000126	0.00361	CbGeAlD
Indomethacin—ABCC2—lymph node—hematologic cancer	0.000125	0.00356	CbGeAlD
Indomethacin—PTGS2—blood—hematologic cancer	0.000121	0.00345	CbGeAlD
Indomethacin—AKR1C3—Podofilox—Etoposide—hematologic cancer	0.000119	0.0643	CbGdCrCtD
Indomethacin—PTGS2—bone marrow—hematologic cancer	0.000117	0.00334	CbGeAlD
Indomethacin—ABCB1—hematopoietic system—hematologic cancer	0.000113	0.00322	CbGeAlD
Indomethacin—PTGS1—lung—hematologic cancer	0.000111	0.00316	CbGeAlD
Indomethacin—ABCC1—lymph node—hematologic cancer	0.00011	0.00313	CbGeAlD
Indomethacin—PTGS2—lung—hematologic cancer	0.000106	0.00302	CbGeAlD
Indomethacin—PTGS1—testis—hematologic cancer	0.000105	0.00298	CbGeAlD
Indomethacin—AKR1C3—Vinblastine—Vinorelbine—hematologic cancer	0.000102	0.0553	CbGdCrCtD
Indomethacin—AKR1C3—Vincristine—Vinblastine—hematologic cancer	0.000102	0.055	CbGdCrCtD
Indomethacin—ABCB1—gonad—hematologic cancer	8.57e-05	0.00245	CbGeAlD
Indomethacin—AKR1C3—Vinblastine—Vincristine—hematologic cancer	8.18e-05	0.0442	CbGdCrCtD
Indomethacin—PTGS1—lymph node—hematologic cancer	7.58e-05	0.00216	CbGeAlD
Indomethacin—ABCB1—blood—hematologic cancer	7.47e-05	0.00213	CbGeAlD
Indomethacin—PTGS2—lymph node—hematologic cancer	7.24e-05	0.00207	CbGeAlD
Indomethacin—ABCB1—bone marrow—hematologic cancer	7.23e-05	0.00206	CbGeAlD
Indomethacin—ABCB1—lung—hematologic cancer	6.55e-05	0.00187	CbGeAlD
Indomethacin—Naproxen—ALB—hematologic cancer	6.41e-05	0.11	CrCbGaD
Indomethacin—ABCB1—testis—hematologic cancer	6.18e-05	0.00176	CbGeAlD
Indomethacin—PPARG—Teniposide—Etoposide—hematologic cancer	5.85e-05	0.0316	CbGdCrCtD
Indomethacin—ABCB1—lymph node—hematologic cancer	4.48e-05	0.00128	CbGeAlD
Indomethacin—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	2.48e-05	0.0134	CbGdCrCtD
Indomethacin—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	2.48e-05	0.0134	CbGdCrCtD
Indomethacin—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	2.42e-05	0.0131	CbGdCrCtD
Indomethacin—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	1.49e-05	0.00808	CbGdCrCtD
Indomethacin—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	1.49e-05	0.00808	CbGdCrCtD
Indomethacin—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	1.46e-05	0.00789	CbGdCrCtD
Indomethacin—Erythema—Methotrexate—hematologic cancer	1.02e-05	9e-05	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—hematologic cancer	1.02e-05	9e-05	CcSEcCtD
Indomethacin—Headache—Gemcitabine—hematologic cancer	1.02e-05	9e-05	CcSEcCtD
Indomethacin—Nausea—Vincristine—hematologic cancer	1.02e-05	9e-05	CcSEcCtD
Indomethacin—Flushing—Epirubicin—hematologic cancer	1.01e-05	8.98e-05	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—hematologic cancer	1.01e-05	8.96e-05	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—hematologic cancer	1.01e-05	8.96e-05	CcSEcCtD
Indomethacin—Hypersensitivity—Prednisolone—hematologic cancer	1.01e-05	8.92e-05	CcSEcCtD
Indomethacin—Dyspepsia—Dexamethasone—hematologic cancer	1e-05	8.89e-05	CcSEcCtD
Indomethacin—Dyspepsia—Betamethasone—hematologic cancer	1e-05	8.89e-05	CcSEcCtD
Indomethacin—Urticaria—Triamcinolone—hematologic cancer	9.98e-06	8.84e-05	CcSEcCtD
Indomethacin—Asthenia—Etoposide—hematologic cancer	9.94e-06	8.8e-05	CcSEcCtD
Indomethacin—Body temperature increased—Triamcinolone—hematologic cancer	9.93e-06	8.8e-05	CcSEcCtD
Indomethacin—Oedema—Prednisone—hematologic cancer	9.93e-06	8.79e-05	CcSEcCtD
Indomethacin—Anaphylactic shock—Prednisone—hematologic cancer	9.93e-06	8.79e-05	CcSEcCtD
Indomethacin—Decreased appetite—Betamethasone—hematologic cancer	9.91e-06	8.78e-05	CcSEcCtD
Indomethacin—Decreased appetite—Dexamethasone—hematologic cancer	9.91e-06	8.78e-05	CcSEcCtD
Indomethacin—Nausea—Mitoxantrone—hematologic cancer	9.89e-06	8.76e-05	CcSEcCtD
Indomethacin—Nausea—Irinotecan—hematologic cancer	9.89e-06	8.76e-05	CcSEcCtD
Indomethacin—Fatigue—Dexamethasone—hematologic cancer	9.83e-06	8.71e-05	CcSEcCtD
Indomethacin—Fatigue—Betamethasone—hematologic cancer	9.83e-06	8.71e-05	CcSEcCtD
Indomethacin—Pruritus—Etoposide—hematologic cancer	9.8e-06	8.68e-05	CcSEcCtD
Indomethacin—Shock—Prednisone—hematologic cancer	9.77e-06	8.65e-05	CcSEcCtD
Indomethacin—Arrhythmia—Epirubicin—hematologic cancer	9.76e-06	8.65e-05	CcSEcCtD
Indomethacin—Pain—Betamethasone—hematologic cancer	9.75e-06	8.63e-05	CcSEcCtD
Indomethacin—Pain—Dexamethasone—hematologic cancer	9.75e-06	8.63e-05	CcSEcCtD
Indomethacin—Tachycardia—Prednisone—hematologic cancer	9.69e-06	8.58e-05	CcSEcCtD
Indomethacin—Alopecia—Epirubicin—hematologic cancer	9.66e-06	8.55e-05	CcSEcCtD
Indomethacin—Nausea—Gemcitabine—hematologic cancer	9.63e-06	8.53e-05	CcSEcCtD
Indomethacin—Vomiting—Cisplatin—hematologic cancer	9.61e-06	8.52e-05	CcSEcCtD
Indomethacin—Hyperhidrosis—Prednisone—hematologic cancer	9.6e-06	8.5e-05	CcSEcCtD
Indomethacin—Vision blurred—Methotrexate—hematologic cancer	9.58e-06	8.49e-05	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—hematologic cancer	9.56e-06	8.47e-05	CcSEcCtD
Indomethacin—Rash—Cisplatin—hematologic cancer	9.53e-06	8.44e-05	CcSEcCtD
Indomethacin—Dermatitis—Cisplatin—hematologic cancer	9.52e-06	8.44e-05	CcSEcCtD
Indomethacin—Erythema—Epirubicin—hematologic cancer	9.51e-06	8.43e-05	CcSEcCtD
Indomethacin—Diarrhoea—Etoposide—hematologic cancer	9.48e-06	8.39e-05	CcSEcCtD
Indomethacin—Anorexia—Prednisone—hematologic cancer	9.46e-06	8.38e-05	CcSEcCtD
Indomethacin—Ill-defined disorder—Methotrexate—hematologic cancer	9.43e-06	8.35e-05	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—hematologic cancer	9.43e-06	8.35e-05	CcSEcCtD
Indomethacin—Anaemia—Methotrexate—hematologic cancer	9.39e-06	8.32e-05	CcSEcCtD
Indomethacin—Feeling abnormal—Betamethasone—hematologic cancer	9.39e-06	8.32e-05	CcSEcCtD
Indomethacin—Feeling abnormal—Dexamethasone—hematologic cancer	9.39e-06	8.32e-05	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—hematologic cancer	9.38e-06	8.31e-05	CcSEcCtD
Indomethacin—Flatulence—Epirubicin—hematologic cancer	9.37e-06	8.3e-05	CcSEcCtD
Indomethacin—Tension—Epirubicin—hematologic cancer	9.33e-06	8.27e-05	CcSEcCtD
Indomethacin—Gastrointestinal pain—Betamethasone—hematologic cancer	9.32e-06	8.26e-05	CcSEcCtD
Indomethacin—Gastrointestinal pain—Dexamethasone—hematologic cancer	9.32e-06	8.26e-05	CcSEcCtD
Indomethacin—Hypersensitivity—Triamcinolone—hematologic cancer	9.26e-06	8.2e-05	CcSEcCtD
Indomethacin—Nervousness—Epirubicin—hematologic cancer	9.24e-06	8.18e-05	CcSEcCtD
Indomethacin—Malaise—Methotrexate—hematologic cancer	9.17e-06	8.12e-05	CcSEcCtD
Indomethacin—Dizziness—Etoposide—hematologic cancer	9.16e-06	8.11e-05	CcSEcCtD
Indomethacin—Vertigo—Methotrexate—hematologic cancer	9.13e-06	8.09e-05	CcSEcCtD
Indomethacin—Leukopenia—Methotrexate—hematologic cancer	9.1e-06	8.06e-05	CcSEcCtD
Indomethacin—Urticaria—Betamethasone—hematologic cancer	9.05e-06	8.02e-05	CcSEcCtD
Indomethacin—Urticaria—Dexamethasone—hematologic cancer	9.05e-06	8.02e-05	CcSEcCtD
Indomethacin—Dizziness—Prednisolone—hematologic cancer	9.03e-06	8e-05	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—hematologic cancer	9.03e-06	8e-05	CcSEcCtD
Indomethacin—Asthenia—Triamcinolone—hematologic cancer	9.01e-06	7.98e-05	CcSEcCtD
Indomethacin—Abdominal pain—Betamethasone—hematologic cancer	9.01e-06	7.98e-05	CcSEcCtD
Indomethacin—Body temperature increased—Betamethasone—hematologic cancer	9.01e-06	7.98e-05	CcSEcCtD
Indomethacin—Abdominal pain—Dexamethasone—hematologic cancer	9.01e-06	7.98e-05	CcSEcCtD
Indomethacin—Body temperature increased—Dexamethasone—hematologic cancer	9.01e-06	7.98e-05	CcSEcCtD
Indomethacin—Nausea—Cisplatin—hematologic cancer	8.98e-06	7.95e-05	CcSEcCtD
Indomethacin—Insomnia—Prednisone—hematologic cancer	8.98e-06	7.95e-05	CcSEcCtD
Indomethacin—Vision blurred—Epirubicin—hematologic cancer	8.96e-06	7.94e-05	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—hematologic cancer	8.93e-06	7.92e-05	CcSEcCtD
Indomethacin—Paraesthesia—Prednisone—hematologic cancer	8.91e-06	7.9e-05	CcSEcCtD
Indomethacin—Pruritus—Triamcinolone—hematologic cancer	8.89e-06	7.87e-05	CcSEcCtD
Indomethacin—Ill-defined disorder—Epirubicin—hematologic cancer	8.83e-06	7.82e-05	CcSEcCtD
Indomethacin—Convulsion—Methotrexate—hematologic cancer	8.81e-06	7.8e-05	CcSEcCtD
Indomethacin—Vomiting—Etoposide—hematologic cancer	8.81e-06	7.8e-05	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—hematologic cancer	8.8e-06	7.8e-05	CcSEcCtD
Indomethacin—Anaemia—Epirubicin—hematologic cancer	8.79e-06	7.79e-05	CcSEcCtD
Indomethacin—Dyspepsia—Prednisone—hematologic cancer	8.74e-06	7.74e-05	CcSEcCtD
Indomethacin—Rash—Etoposide—hematologic cancer	8.73e-06	7.74e-05	CcSEcCtD
Indomethacin—Dermatitis—Etoposide—hematologic cancer	8.72e-06	7.73e-05	CcSEcCtD
Indomethacin—Headache—Etoposide—hematologic cancer	8.68e-06	7.69e-05	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—hematologic cancer	8.67e-06	7.68e-05	CcSEcCtD
Indomethacin—Chest pain—Methotrexate—hematologic cancer	8.65e-06	7.67e-05	CcSEcCtD
Indomethacin—Tension—Doxorubicin—hematologic cancer	8.64e-06	7.65e-05	CcSEcCtD
Indomethacin—Decreased appetite—Prednisone—hematologic cancer	8.63e-06	7.64e-05	CcSEcCtD
Indomethacin—Rash—Prednisolone—hematologic cancer	8.61e-06	7.63e-05	CcSEcCtD
Indomethacin—Dermatitis—Prednisolone—hematologic cancer	8.6e-06	7.62e-05	CcSEcCtD
Indomethacin—Malaise—Epirubicin—hematologic cancer	8.58e-06	7.6e-05	CcSEcCtD
Indomethacin—Fatigue—Prednisone—hematologic cancer	8.56e-06	7.58e-05	CcSEcCtD
Indomethacin—Headache—Prednisolone—hematologic cancer	8.56e-06	7.58e-05	CcSEcCtD
Indomethacin—Discomfort—Methotrexate—hematologic cancer	8.55e-06	7.57e-05	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—hematologic cancer	8.55e-06	7.57e-05	CcSEcCtD
Indomethacin—Vertigo—Epirubicin—hematologic cancer	8.55e-06	7.57e-05	CcSEcCtD
Indomethacin—Syncope—Epirubicin—hematologic cancer	8.53e-06	7.56e-05	CcSEcCtD
Indomethacin—Leukopenia—Epirubicin—hematologic cancer	8.51e-06	7.54e-05	CcSEcCtD
Indomethacin—Constipation—Prednisone—hematologic cancer	8.49e-06	7.52e-05	CcSEcCtD
Indomethacin—Palpitations—Epirubicin—hematologic cancer	8.41e-06	7.45e-05	CcSEcCtD
Indomethacin—Confusional state—Methotrexate—hematologic cancer	8.36e-06	7.41e-05	CcSEcCtD
Indomethacin—Loss of consciousness—Epirubicin—hematologic cancer	8.36e-06	7.41e-05	CcSEcCtD
Indomethacin—Dizziness—Triamcinolone—hematologic cancer	8.31e-06	7.36e-05	CcSEcCtD
Indomethacin—Anaphylactic shock—Methotrexate—hematologic cancer	8.3e-06	7.35e-05	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—hematologic cancer	8.29e-06	7.35e-05	CcSEcCtD
Indomethacin—Convulsion—Epirubicin—hematologic cancer	8.24e-06	7.3e-05	CcSEcCtD
Indomethacin—Nausea—Etoposide—hematologic cancer	8.23e-06	7.29e-05	CcSEcCtD
Indomethacin—Hypertension—Epirubicin—hematologic cancer	8.21e-06	7.28e-05	CcSEcCtD
Indomethacin—Feeling abnormal—Prednisone—hematologic cancer	8.18e-06	7.25e-05	CcSEcCtD
Indomethacin—Asthenia—Dexamethasone—hematologic cancer	8.18e-06	7.24e-05	CcSEcCtD
Indomethacin—Asthenia—Betamethasone—hematologic cancer	8.18e-06	7.24e-05	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—hematologic cancer	8.17e-06	7.23e-05	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—hematologic cancer	8.13e-06	7.21e-05	CcSEcCtD
Indomethacin—Thrombocytopenia—Methotrexate—hematologic cancer	8.12e-06	7.2e-05	CcSEcCtD
Indomethacin—Gastrointestinal pain—Prednisone—hematologic cancer	8.12e-06	7.19e-05	CcSEcCtD
Indomethacin—Nausea—Prednisolone—hematologic cancer	8.11e-06	7.19e-05	CcSEcCtD
Indomethacin—Chest pain—Epirubicin—hematologic cancer	8.1e-06	7.17e-05	CcSEcCtD
Indomethacin—Anxiety—Epirubicin—hematologic cancer	8.07e-06	7.15e-05	CcSEcCtD
Indomethacin—Pruritus—Betamethasone—hematologic cancer	8.06e-06	7.14e-05	CcSEcCtD
Indomethacin—Pruritus—Dexamethasone—hematologic cancer	8.06e-06	7.14e-05	CcSEcCtD
Indomethacin—Hyperhidrosis—Methotrexate—hematologic cancer	8.02e-06	7.1e-05	CcSEcCtD
Indomethacin—Discomfort—Epirubicin—hematologic cancer	8e-06	7.09e-05	CcSEcCtD
Indomethacin—Vomiting—Triamcinolone—hematologic cancer	7.99e-06	7.08e-05	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—hematologic cancer	7.94e-06	7.03e-05	CcSEcCtD
Indomethacin—Rash—Triamcinolone—hematologic cancer	7.92e-06	7.02e-05	CcSEcCtD
Indomethacin—Dermatitis—Triamcinolone—hematologic cancer	7.91e-06	7.01e-05	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—hematologic cancer	7.91e-06	7.01e-05	CcSEcCtD
Indomethacin—Anorexia—Methotrexate—hematologic cancer	7.91e-06	7.01e-05	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—hematologic cancer	7.89e-06	6.99e-05	CcSEcCtD
Indomethacin—Urticaria—Prednisone—hematologic cancer	7.89e-06	6.99e-05	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—hematologic cancer	7.88e-06	6.98e-05	CcSEcCtD
Indomethacin—Headache—Triamcinolone—hematologic cancer	7.87e-06	6.97e-05	CcSEcCtD
Indomethacin—Body temperature increased—Prednisone—hematologic cancer	7.85e-06	6.95e-05	CcSEcCtD
Indomethacin—Abdominal pain—Prednisone—hematologic cancer	7.85e-06	6.95e-05	CcSEcCtD
Indomethacin—Confusional state—Epirubicin—hematologic cancer	7.83e-06	6.93e-05	CcSEcCtD
Indomethacin—Diarrhoea—Betamethasone—hematologic cancer	7.8e-06	6.91e-05	CcSEcCtD
Indomethacin—Diarrhoea—Dexamethasone—hematologic cancer	7.8e-06	6.91e-05	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—hematologic cancer	7.78e-06	6.89e-05	CcSEcCtD
Indomethacin—Oedema—Epirubicin—hematologic cancer	7.76e-06	6.88e-05	CcSEcCtD
Indomethacin—Anaphylactic shock—Epirubicin—hematologic cancer	7.76e-06	6.88e-05	CcSEcCtD
Indomethacin—Hypotension—Methotrexate—hematologic cancer	7.75e-06	6.87e-05	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—hematologic cancer	7.74e-06	6.85e-05	CcSEcCtD
Indomethacin—Shock—Epirubicin—hematologic cancer	7.64e-06	6.77e-05	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—hematologic cancer	7.63e-06	6.76e-05	CcSEcCtD
Indomethacin—Thrombocytopenia—Epirubicin—hematologic cancer	7.6e-06	6.73e-05	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—hematologic cancer	7.6e-06	6.73e-05	CcSEcCtD
Indomethacin—Tachycardia—Epirubicin—hematologic cancer	7.58e-06	6.71e-05	CcSEcCtD
Indomethacin—Dizziness—Dexamethasone—hematologic cancer	7.54e-06	6.68e-05	CcSEcCtD
Indomethacin—Dizziness—Betamethasone—hematologic cancer	7.54e-06	6.68e-05	CcSEcCtD
Indomethacin—Hyperhidrosis—Epirubicin—hematologic cancer	7.5e-06	6.65e-05	CcSEcCtD
Indomethacin—Insomnia—Methotrexate—hematologic cancer	7.5e-06	6.65e-05	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—hematologic cancer	7.49e-06	6.64e-05	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—hematologic cancer	7.47e-06	6.62e-05	CcSEcCtD
Indomethacin—Nausea—Triamcinolone—hematologic cancer	7.46e-06	6.61e-05	CcSEcCtD
Indomethacin—Paraesthesia—Methotrexate—hematologic cancer	7.45e-06	6.6e-05	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—hematologic cancer	7.4e-06	6.56e-05	CcSEcCtD
Indomethacin—Anorexia—Epirubicin—hematologic cancer	7.4e-06	6.56e-05	CcSEcCtD
Indomethacin—Dyspnoea—Methotrexate—hematologic cancer	7.4e-06	6.55e-05	CcSEcCtD
Indomethacin—Somnolence—Methotrexate—hematologic cancer	7.37e-06	6.53e-05	CcSEcCtD
Indomethacin—Hypersensitivity—Prednisone—hematologic cancer	7.31e-06	6.48e-05	CcSEcCtD
Indomethacin—Dyspepsia—Methotrexate—hematologic cancer	7.3e-06	6.47e-05	CcSEcCtD
Indomethacin—Hypotension—Epirubicin—hematologic cancer	7.25e-06	6.43e-05	CcSEcCtD
Indomethacin—Vomiting—Dexamethasone—hematologic cancer	7.25e-06	6.42e-05	CcSEcCtD
Indomethacin—Vomiting—Betamethasone—hematologic cancer	7.25e-06	6.42e-05	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—hematologic cancer	7.24e-06	6.42e-05	CcSEcCtD
Indomethacin—Decreased appetite—Methotrexate—hematologic cancer	7.21e-06	6.39e-05	CcSEcCtD
Indomethacin—Rash—Betamethasone—hematologic cancer	7.19e-06	6.37e-05	CcSEcCtD
Indomethacin—Rash—Dexamethasone—hematologic cancer	7.19e-06	6.37e-05	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—hematologic cancer	7.18e-06	6.36e-05	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—hematologic cancer	7.18e-06	6.36e-05	CcSEcCtD
Indomethacin—Dermatitis—Dexamethasone—hematologic cancer	7.18e-06	6.36e-05	CcSEcCtD
Indomethacin—Dermatitis—Betamethasone—hematologic cancer	7.18e-06	6.36e-05	CcSEcCtD
Indomethacin—Fatigue—Methotrexate—hematologic cancer	7.15e-06	6.34e-05	CcSEcCtD
Indomethacin—Headache—Dexamethasone—hematologic cancer	7.14e-06	6.33e-05	CcSEcCtD
Indomethacin—Headache—Betamethasone—hematologic cancer	7.14e-06	6.33e-05	CcSEcCtD
Indomethacin—Asthenia—Prednisone—hematologic cancer	7.12e-06	6.31e-05	CcSEcCtD
Indomethacin—Pain—Methotrexate—hematologic cancer	7.09e-06	6.28e-05	CcSEcCtD
Indomethacin—Shock—Doxorubicin—hematologic cancer	7.07e-06	6.26e-05	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—hematologic cancer	7.03e-06	6.23e-05	CcSEcCtD
Indomethacin—Pruritus—Prednisone—hematologic cancer	7.02e-06	6.22e-05	CcSEcCtD
Indomethacin—Insomnia—Epirubicin—hematologic cancer	7.02e-06	6.22e-05	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—hematologic cancer	7.01e-06	6.21e-05	CcSEcCtD
Indomethacin—Paraesthesia—Epirubicin—hematologic cancer	6.97e-06	6.18e-05	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—hematologic cancer	6.94e-06	6.15e-05	CcSEcCtD
Indomethacin—Dyspnoea—Epirubicin—hematologic cancer	6.92e-06	6.13e-05	CcSEcCtD
Indomethacin—Somnolence—Epirubicin—hematologic cancer	6.9e-06	6.11e-05	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—hematologic cancer	6.85e-06	6.07e-05	CcSEcCtD
Indomethacin—Feeling abnormal—Methotrexate—hematologic cancer	6.84e-06	6.06e-05	CcSEcCtD
Indomethacin—Dyspepsia—Epirubicin—hematologic cancer	6.83e-06	6.05e-05	CcSEcCtD
Indomethacin—Diarrhoea—Prednisone—hematologic cancer	6.79e-06	6.02e-05	CcSEcCtD
Indomethacin—Gastrointestinal pain—Methotrexate—hematologic cancer	6.78e-06	6.01e-05	CcSEcCtD
Indomethacin—Nausea—Dexamethasone—hematologic cancer	6.77e-06	6e-05	CcSEcCtD
Indomethacin—Nausea—Betamethasone—hematologic cancer	6.77e-06	6e-05	CcSEcCtD
Indomethacin—Decreased appetite—Epirubicin—hematologic cancer	6.75e-06	5.98e-05	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—hematologic cancer	6.71e-06	5.95e-05	CcSEcCtD
Indomethacin—Fatigue—Epirubicin—hematologic cancer	6.69e-06	5.93e-05	CcSEcCtD
Indomethacin—Constipation—Epirubicin—hematologic cancer	6.64e-06	5.88e-05	CcSEcCtD
Indomethacin—Pain—Epirubicin—hematologic cancer	6.64e-06	5.88e-05	CcSEcCtD
Indomethacin—Urticaria—Methotrexate—hematologic cancer	6.59e-06	5.84e-05	CcSEcCtD
Indomethacin—Dizziness—Prednisone—hematologic cancer	6.56e-06	5.82e-05	CcSEcCtD
Indomethacin—Abdominal pain—Methotrexate—hematologic cancer	6.56e-06	5.81e-05	CcSEcCtD
Indomethacin—Body temperature increased—Methotrexate—hematologic cancer	6.56e-06	5.81e-05	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—hematologic cancer	6.5e-06	5.76e-05	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—hematologic cancer	6.45e-06	5.71e-05	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—hematologic cancer	6.4e-06	5.67e-05	CcSEcCtD
Indomethacin—Feeling abnormal—Epirubicin—hematologic cancer	6.4e-06	5.67e-05	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—hematologic cancer	6.39e-06	5.66e-05	CcSEcCtD
Indomethacin—Gastrointestinal pain—Epirubicin—hematologic cancer	6.35e-06	5.62e-05	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—hematologic cancer	6.32e-06	5.6e-05	CcSEcCtD
Indomethacin—Vomiting—Prednisone—hematologic cancer	6.31e-06	5.59e-05	CcSEcCtD
Indomethacin—Rash—Prednisone—hematologic cancer	6.26e-06	5.54e-05	CcSEcCtD
Indomethacin—Dermatitis—Prednisone—hematologic cancer	6.25e-06	5.54e-05	CcSEcCtD
Indomethacin—Decreased appetite—Doxorubicin—hematologic cancer	6.24e-06	5.53e-05	CcSEcCtD
Indomethacin—Headache—Prednisone—hematologic cancer	6.22e-06	5.51e-05	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—hematologic cancer	6.19e-06	5.49e-05	CcSEcCtD
Indomethacin—Urticaria—Epirubicin—hematologic cancer	6.17e-06	5.46e-05	CcSEcCtD
Indomethacin—Pain—Doxorubicin—hematologic cancer	6.14e-06	5.44e-05	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—hematologic cancer	6.14e-06	5.44e-05	CcSEcCtD
Indomethacin—Abdominal pain—Epirubicin—hematologic cancer	6.14e-06	5.44e-05	CcSEcCtD
Indomethacin—Body temperature increased—Epirubicin—hematologic cancer	6.14e-06	5.44e-05	CcSEcCtD
Indomethacin—Hypersensitivity—Methotrexate—hematologic cancer	6.11e-06	5.41e-05	CcSEcCtD
Indomethacin—Asthenia—Methotrexate—hematologic cancer	5.95e-06	5.27e-05	CcSEcCtD
Indomethacin—Feeling abnormal—Doxorubicin—hematologic cancer	5.92e-06	5.24e-05	CcSEcCtD
Indomethacin—Nausea—Prednisone—hematologic cancer	5.9e-06	5.22e-05	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—hematologic cancer	5.87e-06	5.2e-05	CcSEcCtD
Indomethacin—Pruritus—Methotrexate—hematologic cancer	5.87e-06	5.2e-05	CcSEcCtD
Indomethacin—Hypersensitivity—Epirubicin—hematologic cancer	5.72e-06	5.07e-05	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—hematologic cancer	5.71e-06	5.06e-05	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—hematologic cancer	5.68e-06	5.03e-05	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—hematologic cancer	5.68e-06	5.03e-05	CcSEcCtD
Indomethacin—Diarrhoea—Methotrexate—hematologic cancer	5.68e-06	5.03e-05	CcSEcCtD
Indomethacin—Asthenia—Epirubicin—hematologic cancer	5.57e-06	4.93e-05	CcSEcCtD
Indomethacin—Pruritus—Epirubicin—hematologic cancer	5.49e-06	4.87e-05	CcSEcCtD
Indomethacin—Dizziness—Methotrexate—hematologic cancer	5.49e-06	4.86e-05	CcSEcCtD
Indomethacin—Diarrhoea—Epirubicin—hematologic cancer	5.31e-06	4.71e-05	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—hematologic cancer	5.29e-06	4.69e-05	CcSEcCtD
Indomethacin—Vomiting—Methotrexate—hematologic cancer	5.27e-06	4.67e-05	CcSEcCtD
Indomethacin—Rash—Methotrexate—hematologic cancer	5.23e-06	4.63e-05	CcSEcCtD
Indomethacin—Dermatitis—Methotrexate—hematologic cancer	5.23e-06	4.63e-05	CcSEcCtD
Indomethacin—Headache—Methotrexate—hematologic cancer	5.2e-06	4.6e-05	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—hematologic cancer	5.15e-06	4.57e-05	CcSEcCtD
Indomethacin—Dizziness—Epirubicin—hematologic cancer	5.13e-06	4.55e-05	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—hematologic cancer	5.08e-06	4.5e-05	CcSEcCtD
Indomethacin—Vomiting—Epirubicin—hematologic cancer	4.94e-06	4.37e-05	CcSEcCtD
Indomethacin—Nausea—Methotrexate—hematologic cancer	4.93e-06	4.37e-05	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—hematologic cancer	4.91e-06	4.35e-05	CcSEcCtD
Indomethacin—Rash—Epirubicin—hematologic cancer	4.89e-06	4.34e-05	CcSEcCtD
Indomethacin—Dermatitis—Epirubicin—hematologic cancer	4.89e-06	4.33e-05	CcSEcCtD
Indomethacin—Headache—Epirubicin—hematologic cancer	4.86e-06	4.31e-05	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—hematologic cancer	4.75e-06	4.21e-05	CcSEcCtD
Indomethacin—Nausea—Epirubicin—hematologic cancer	4.61e-06	4.09e-05	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—hematologic cancer	4.57e-06	4.05e-05	CcSEcCtD
Indomethacin—Rash—Doxorubicin—hematologic cancer	4.53e-06	4.01e-05	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—hematologic cancer	4.52e-06	4.01e-05	CcSEcCtD
Indomethacin—Headache—Doxorubicin—hematologic cancer	4.5e-06	3.99e-05	CcSEcCtD
Indomethacin—Nausea—Doxorubicin—hematologic cancer	4.27e-06	3.78e-05	CcSEcCtD
Indomethacin—AKR1C3—Signaling Pathways—TGFB1—hematologic cancer	8.77e-07	1.22e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.73e-07	1.21e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—hematologic cancer	8.71e-07	1.21e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	8.67e-07	1.2e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CREBBP—hematologic cancer	8.67e-07	1.2e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CD—hematologic cancer	8.65e-07	1.2e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCND1—hematologic cancer	8.65e-07	1.2e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MAPK3—hematologic cancer	8.64e-07	1.2e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.63e-07	1.2e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—JUN—hematologic cancer	8.63e-07	1.2e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGFR3—hematologic cancer	8.59e-07	1.19e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ALB—hematologic cancer	8.54e-07	1.18e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.52e-07	1.18e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—hematologic cancer	8.48e-07	1.18e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3R1—hematologic cancer	8.47e-07	1.17e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3R1—hematologic cancer	8.47e-07	1.17e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1B—hematologic cancer	8.45e-07	1.17e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CD44—hematologic cancer	8.43e-07	1.17e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NQO1—hematologic cancer	8.43e-07	1.17e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—hematologic cancer	8.4e-07	1.17e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	8.38e-07	1.16e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDKN1A—hematologic cancer	8.37e-07	1.16e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTEN—hematologic cancer	8.35e-07	1.16e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—EP300—hematologic cancer	8.32e-07	1.15e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CG—hematologic cancer	8.32e-07	1.15e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTEN—hematologic cancer	8.32e-07	1.15e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTEN—hematologic cancer	8.32e-07	1.15e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.25e-07	1.14e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NQO1—hematologic cancer	8.23e-07	1.14e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CD44—hematologic cancer	8.23e-07	1.14e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	8.22e-07	1.14e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3R1—hematologic cancer	8.17e-07	1.13e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK8—hematologic cancer	8.17e-07	1.13e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.15e-07	1.13e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—hematologic cancer	8.14e-07	1.13e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—BAD—hematologic cancer	8.14e-07	1.13e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—hematologic cancer	8.13e-07	1.13e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—hematologic cancer	8.13e-07	1.13e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—hematologic cancer	8.12e-07	1.13e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—SRC—hematologic cancer	8.09e-07	1.12e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOTCH1—hematologic cancer	8.06e-07	1.12e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYCS—hematologic cancer	7.98e-07	1.11e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EP300—hematologic cancer	7.96e-07	1.1e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.94e-07	1.1e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—EP300—hematologic cancer	7.93e-07	1.1e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—EP300—hematologic cancer	7.93e-07	1.1e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	7.92e-07	1.1e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD80—hematologic cancer	7.9e-07	1.1e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KIT—hematologic cancer	7.89e-07	1.09e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—hematologic cancer	7.88e-07	1.09e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTEN—hematologic cancer	7.86e-07	1.09e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MTHFR—hematologic cancer	7.86e-07	1.09e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTP1—hematologic cancer	7.83e-07	1.09e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CB—hematologic cancer	7.82e-07	1.08e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CB—hematologic cancer	7.82e-07	1.08e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1A—hematologic cancer	7.8e-07	1.08e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NRAS—hematologic cancer	7.79e-07	1.08e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYCS—hematologic cancer	7.78e-07	1.08e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTEN—hematologic cancer	7.78e-07	1.08e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	7.76e-07	1.08e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTPN11—hematologic cancer	7.75e-07	1.07e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SRC—hematologic cancer	7.74e-07	1.07e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—hematologic cancer	7.74e-07	1.07e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HSP90AA1—hematologic cancer	7.73e-07	1.07e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CREBBP—hematologic cancer	7.71e-07	1.07e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CD44—hematologic cancer	7.69e-07	1.07e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NQO1—hematologic cancer	7.69e-07	1.07e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.58e-07	1.05e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CB—hematologic cancer	7.54e-07	1.05e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—hematologic cancer	7.54e-07	1.05e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.53e-07	1.04e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CREB1—hematologic cancer	7.51e-07	1.04e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—EP300—hematologic cancer	7.5e-07	1.04e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—hematologic cancer	7.47e-07	1.03e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—hematologic cancer	7.47e-07	1.03e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK3—hematologic cancer	7.46e-07	1.03e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRAS—hematologic cancer	7.45e-07	1.03e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EP300—hematologic cancer	7.42e-07	1.03e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—BRAF—hematologic cancer	7.41e-07	1.03e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCB1—hematologic cancer	7.41e-07	1.03e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6R—hematologic cancer	7.32e-07	1.02e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CD—hematologic cancer	7.31e-07	1.01e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CREBBP—hematologic cancer	7.31e-07	1.01e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—hematologic cancer	7.29e-07	1.01e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYCS—hematologic cancer	7.27e-07	1.01e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTEN—hematologic cancer	7.24e-07	1e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—hematologic cancer	7.23e-07	1e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	7.23e-07	1e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—hematologic cancer	7.22e-07	1e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—hematologic cancer	7.22e-07	1e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SRC—hematologic cancer	7.22e-07	1e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NCOR1—hematologic cancer	7.2e-07	9.98e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTM1—hematologic cancer	7.2e-07	9.98e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	7.17e-07	9.93e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK3—hematologic cancer	7.13e-07	9.89e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.13e-07	9.89e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTP1—hematologic cancer	7.03e-07	9.74e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAP2K1—hematologic cancer	6.98e-07	9.67e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—hematologic cancer	6.96e-07	9.65e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRAS—hematologic cancer	6.94e-07	9.62e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—hematologic cancer	6.94e-07	9.62e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CD—hematologic cancer	6.93e-07	9.61e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.93e-07	9.6e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—hematologic cancer	6.92e-07	9.59e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—hematologic cancer	6.91e-07	9.57e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3R1—hematologic cancer	6.91e-07	9.57e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—EP300—hematologic cancer	6.91e-07	9.57e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTP1—hematologic cancer	6.86e-07	9.51e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.8e-07	9.43e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTEN—hematologic cancer	6.76e-07	9.37e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTEN—hematologic cancer	6.76e-07	9.37e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—hematologic cancer	6.7e-07	9.29e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCB1—hematologic cancer	6.65e-07	9.22e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK3—hematologic cancer	6.65e-07	9.22e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGF2—hematologic cancer	6.64e-07	9.2e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—hematologic cancer	6.61e-07	9.16e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CG—hematologic cancer	6.6e-07	9.16e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3R1—hematologic cancer	6.55e-07	9.08e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTEN—hematologic cancer	6.52e-07	9.03e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.5e-07	9.01e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—hematologic cancer	6.47e-07	8.96e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NCOR1—hematologic cancer	6.46e-07	8.95e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTM1—hematologic cancer	6.46e-07	8.95e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—hematologic cancer	6.45e-07	8.94e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—EP300—hematologic cancer	6.44e-07	8.93e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—EP300—hematologic cancer	6.44e-07	8.93e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—hematologic cancer	6.41e-07	8.89e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTP1—hematologic cancer	6.41e-07	8.89e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CB—hematologic cancer	6.37e-07	8.84e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—JAK2—hematologic cancer	6.36e-07	8.82e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MTHFR—hematologic cancer	6.36e-07	8.82e-06	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—hematologic cancer	6.32e-07	8.77e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTM1—hematologic cancer	6.31e-07	8.74e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NCOR1—hematologic cancer	6.31e-07	8.74e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—EP300—hematologic cancer	6.21e-07	8.61e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MDM2—hematologic cancer	6.21e-07	8.61e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.2e-07	8.6e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTEN—hematologic cancer	6.19e-07	8.58e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—hematologic cancer	6.16e-07	8.53e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CREBBP—hematologic cancer	6.12e-07	8.49e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—hematologic cancer	6.1e-07	8.45e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCB1—hematologic cancer	6.07e-07	8.41e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CB—hematologic cancer	6.04e-07	8.38e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTOR—hematologic cancer	6.04e-07	8.38e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD4—hematologic cancer	6.03e-07	8.36e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—hematologic cancer	5.97e-07	8.28e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—hematologic cancer	5.96e-07	8.26e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—EP300—hematologic cancer	5.91e-07	8.19e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTM1—hematologic cancer	5.89e-07	8.17e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NCOR1—hematologic cancer	5.89e-07	8.17e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—hematologic cancer	5.89e-07	8.16e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—hematologic cancer	5.87e-07	8.13e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—hematologic cancer	5.87e-07	8.13e-06	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—hematologic cancer	5.83e-07	8.08e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CD—hematologic cancer	5.81e-07	8.05e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—hematologic cancer	5.73e-07	7.95e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MTHFR—hematologic cancer	5.71e-07	7.91e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—hematologic cancer	5.7e-07	7.9e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—hematologic cancer	5.7e-07	7.9e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1B—hematologic cancer	5.67e-07	7.86e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.6e-07	7.77e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MTHFR—hematologic cancer	5.57e-07	7.72e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—hematologic cancer	5.55e-07	7.69e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTEN—hematologic cancer	5.51e-07	7.64e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—hematologic cancer	5.49e-07	7.61e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3R1—hematologic cancer	5.48e-07	7.6e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—hematologic cancer	5.45e-07	7.55e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CG—hematologic cancer	5.34e-07	7.41e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—EP300—hematologic cancer	5.25e-07	7.28e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1A—hematologic cancer	5.23e-07	7.25e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTEN—hematologic cancer	5.22e-07	7.24e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—hematologic cancer	5.21e-07	7.23e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MTHFR—hematologic cancer	5.21e-07	7.22e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	5.11e-07	7.08e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—hematologic cancer	5.08e-07	7.04e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CB—hematologic cancer	5.06e-07	7.02e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.03e-07	6.97e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—hematologic cancer	5.03e-07	6.97e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EP300—hematologic cancer	4.98e-07	6.9e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CREBBP—hematologic cancer	4.95e-07	6.87e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—hematologic cancer	4.86e-07	6.74e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SRC—hematologic cancer	4.84e-07	6.71e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—hematologic cancer	4.81e-07	6.67e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CG—hematologic cancer	4.8e-07	6.65e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—hematologic cancer	4.79e-07	6.64e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—hematologic cancer	4.79e-07	6.64e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—hematologic cancer	4.77e-07	6.61e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—hematologic cancer	4.77e-07	6.61e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CD—hematologic cancer	4.7e-07	6.51e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CG—hematologic cancer	4.68e-07	6.49e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—hematologic cancer	4.67e-07	6.47e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRAS—hematologic cancer	4.66e-07	6.46e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—hematologic cancer	4.6e-07	6.37e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.59e-07	6.36e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—hematologic cancer	4.53e-07	6.28e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—hematologic cancer	4.48e-07	6.22e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK3—hematologic cancer	4.46e-07	6.18e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CREBBP—hematologic cancer	4.45e-07	6.16e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3R1—hematologic cancer	4.44e-07	6.15e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.37e-07	6.06e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PTEN—hematologic cancer	4.37e-07	6.06e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	4.37e-07	6.06e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CREBBP—hematologic cancer	4.34e-07	6.02e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—hematologic cancer	4.34e-07	6.02e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—hematologic cancer	4.33e-07	6e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CD—hematologic cancer	4.22e-07	5.85e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—hematologic cancer	4.17e-07	5.78e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—EP300—hematologic cancer	4.17e-07	5.78e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—hematologic cancer	4.16e-07	5.77e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CD—hematologic cancer	4.12e-07	5.71e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CB—hematologic cancer	4.09e-07	5.68e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—hematologic cancer	4.06e-07	5.63e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CREBBP—hematologic cancer	4.06e-07	5.62e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—hematologic cancer	4.01e-07	5.56e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3R1—hematologic cancer	3.98e-07	5.52e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—hematologic cancer	3.89e-07	5.4e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—hematologic cancer	3.89e-07	5.4e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.89e-07	5.39e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—hematologic cancer	3.89e-07	5.39e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.84e-07	5.33e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—hematologic cancer	3.8e-07	5.26e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—hematologic cancer	3.76e-07	5.21e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—hematologic cancer	3.68e-07	5.11e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CB—hematologic cancer	3.68e-07	5.1e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.63e-07	5.03e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.59e-07	4.97e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—hematologic cancer	3.57e-07	4.95e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTEN—hematologic cancer	3.54e-07	4.9e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—hematologic cancer	3.41e-07	4.72e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—EP300—hematologic cancer	3.37e-07	4.68e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.35e-07	4.65e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—hematologic cancer	3.26e-07	4.52e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTEN—hematologic cancer	3.18e-07	4.4e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—hematologic cancer	3.17e-07	4.4e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTEN—hematologic cancer	3.1e-07	4.3e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—hematologic cancer	3.09e-07	4.28e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—EP300—hematologic cancer	3.03e-07	4.2e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—hematologic cancer	3.01e-07	4.17e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—EP300—hematologic cancer	2.96e-07	4.1e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTEN—hematologic cancer	2.9e-07	4.01e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—EP300—hematologic cancer	2.76e-07	3.83e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—hematologic cancer	2.52e-07	3.49e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—hematologic cancer	2.5e-07	3.46e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.24e-07	3.11e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.19e-07	3.03e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.04e-07	2.83e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—hematologic cancer	2.04e-07	2.83e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—hematologic cancer	1.83e-07	2.54e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—hematologic cancer	1.79e-07	2.48e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—hematologic cancer	1.67e-07	2.31e-06	CbGpPWpGaD
